Mount Elizabeth Novena Hospital (MNH) Singapore is the first private hospital in the region to offer proton therapy; kicked off treatment for first patient on 10 May 2023.Centre has already treated more than 100 patients from 16 countries, ranging in ages from 18 months to 85 years. SINGAPORE, May 15, 2024 (GLOBE NEWSWIRE) --  IHH Healthcare, a world-leading integrated healthcare provider, has reinforced its position as Asia’s leading cancer care provider with the official opening of the Mount Elizabeth Proton Therapy Centre in Singapore.

新加坡伊丽莎白山诺维纳医院（MNH）是该地区第一家提供质子治疗的私立医院；2023年5月10日，第一名患者开始接受治疗。该中心已经治疗了来自16个国家的100多名患者，年龄从18个月到85岁不等。新加坡，2024年5月15日（环球通讯社）--随着新加坡伊丽莎白山质子治疗中心的正式开业，世界领先的综合医疗保健提供商IHH Healthcare巩固了其作为亚洲领先癌症护理提供商的地位。

Located in Mount Elizabeth Novena Hospital, the centre makes IHH the first private healthcare provider in the region and in Singapore to offer proton therapy, providing patients unprecedented access to this advanced and highly specialised cancer treatment. Since it began operations in May last year, the centre has treated more than 100 patients from 16 countries, from Singapore and Southeast Asia to as far as the United States, Canada and the United Kingdom.

该中心位于伊丽莎白山诺维纳医院，使IHH成为该地区和新加坡第一家提供质子治疗的私人医疗保健提供者，为患者提供前所未有的先进和高度专业化的癌症治疗。自去年5月开始运作以来，该中心已经治疗了来自16个国家的100多名患者，从新加坡和东南亚到美国、加拿大和英国。

Patients have ranged in ages from 18 months to 85 years. Dr Prem Kumar Nair, Group Chief Executive Officer, IHH Healthcare, said, “Adding proton therapy to IHH’s comprehensive suite of cancer treatment in Singapore solidifies our standing as a Centre Of Excellence for oncology in Asia. Demand has already surpassed our expectations, and we are ramping up further to provide this cutting-edge treatment option to more patients across the region, as part of our purpose to touch lives and transform care.” 'Cancer patients are not alone in their fight against cancer.

患者年龄从18个月到85岁不等。IHH Healthcare集团首席执行官Prem Kumar Nair博士表示，“将质子疗法添加到新加坡IHH的综合癌症治疗套件中，巩固了我们作为亚洲肿瘤学卓越中心的地位。需求已经超过了我们的预期，我们正在进一步加大力度，为该地区更多患者提供这一前沿治疗选择，作为我们接触生活和改变护理的目标的一部分。”“癌症患者并不是唯一与癌症作斗争的人。

IHH Healthcare Singapore’s investment in proton therapy demonstrates our unwavering resolve to provide our patients with the best care,” said Dr Peter Chow, Chief Executive Officer, IHH Healthcare Singapore. “Up to half of.

IHH Healthcare Singapore在质子治疗方面的投资表明了我们为患者提供最佳护理的坚定决心，”IHH Healthcare Singapore首席执行官Peter Chow博士表示。“最多一半。